1. Gerber, A. U., Craig, W. A., Brugger, H. P., Feller, C., Vastola, A. P., Brandel, J.: Impact of dosing intervals on the activity of gentamicin and ticarcillin againstPseudomonas aeruginosa in leukopenic mice. Journal of Infectious Diseases 1983, 147: 910–917.
2. Bundtzen, R. W., Gerber, A. U., Cohn, D., Craig, W. A.: Postantibiotic suppression of bacterial growth. Reviews of Infectious Diseases 1981, 3: 28–37.
3. Gerber, A. U., Craig, W. A.: Aminoglycoside selected subpopulations ofPseudomonas aeruginosa. Characterization and virulence in normal and leukopenic mice. Journal of Laboratory and Clinical Medicine 1982, 100: 671–681.
4. Gerber, A. U., Craig, W. A.: Experimentelle Studien zur Frage des optimalen Dosisintervalls in der Antibiotikatherapie. Schweizerische Medizinische Wochenschrift 1982, 112: 42–45.
5. Hunter, P. A., Rolinson, G. N., Witting, D. A.: Effect of carbenicillin on pseudomonas infection. In: Williams, J. D., Geddes, A. M. (ed.): Chemotherapy. Volume 2 Plenum Press, New York, 1976, p. 289–293.